Inspiremd announces 1-for-15 reverse stock split

Tel aviv, israel, april 14, 2021 (globe newswire) -- inspiremd, inc. (nyse american: nspr, nspr.ws, nspr.wsb), developer of the cguard™ embolic prevention system (eps) for the prevention of stroke caused by the treatment of carotid artery disease (cad), today announced a 1-for-15 reverse split of its common stock, effective as of april 26, 2021. beginning on april 27, 2021, the company's common stock will trade on the nyse american on a split adjusted basis.
NSPR Ratings Summary
NSPR Quant Ranking